Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells (vol 111, pg 336, 2008)

被引：0
|
作者：
Takai, Noriyuki [1 ]
Ueda, Tami [1 ]
Nasu, Kaei [1 ]
Narahara, Hisashi [1 ]
机构：
[1] Oita Univ, Dept Obstet & Gynecol, Fac Med, Yufu, Oita 8795593, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2013年 / 129卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2012.09.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] RETRACTED: Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells (Retracted Article)
    Takai, Noriyuki
    Ueda, Tami
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 336 - 343
  • [2] β-Hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells (Retraction of vol 109, pg 107, 2008)
    Takai, Noriyuki
    Ueda, Tami
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2013, 129 (01) : 269 - 269
  • [3] RETRACTED: β-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells (Retracted Article)
    Takai, Noriyuki
    Ueda, Tami
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    GYNECOLOGIC ONCOLOGY, 2008, 109 (01) : 107 - 114
  • [4] Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells (Retraction of vol 297, pg 198, 2010)
    Li, Haili
    Takai, Noriyuki
    Yuge, Akitoshi
    Furukawa, Yuichi
    Tsuno, Akitoshi
    Tsukamoto, Yoshiyuki
    Kong, Shigi
    Moriyama, Masatsugu
    Narahara, Hisashi
    CANCER LETTERS, 2013, 338 (02) : 331 - 331
  • [5] Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells
    Ueda, Tami
    Takai, Noriyuki
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (02) : 301 - 308
  • [6] RETRACTED: Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells (Retracted article. See vol. 338, pg. 331, 2013)
    Li, Haili
    Takai, Noriyuki
    Yuge, Akitoshi
    Furukawa, Yuichi
    Tsuno, Akitoshi
    Tsukamoto, Yoshiyuki
    Kong, Shigi
    Moriyama, Masatsugu
    Narahara, Hisashi
    CANCER LETTERS, 2010, 297 (02) : 198 - 206
  • [7] Anti-growth factor activities of benzothiophenes in human breast cancer cells
    Freiss, G
    Galtier, F
    Puech, C
    Aknin, C
    Maudelonde, T
    Chalbos, D
    Vignon, F
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 94 (05): : 451 - 460
  • [8] Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer (vol 111, pg 461, 2008)
    Richardson, Debra L.
    Backes, Floor J.
    Seamon, Leigh G.
    Zanagnolo, Vanna
    O'Malley, David M.
    Cohn, David E.
    Fowler, Jeffrey M.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (03) : 603 - 603
  • [9] Anti-Growth and Anti-Metastatic Potential of Raw and Thermally Treated Eragrostis tef Extract in Human Cancer Cells
    Seo, Jina
    Lee, Hwa Jin
    Ju, Jihyeung
    NUTRIENTS, 2024, 16 (16)
  • [10] Erucylphosphocholine induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells (Retraction of vol 32, pg 569, 2011)
    Takai, Noriyuki
    Ueda, Tami
    Ishii, Terukazu
    Kira, Naoko
    Nishida, Masakazu
    Nasu, Kaei
    Narahara, Hisashi
    TUMOR BIOLOGY, 2015, 36 (09) : 7295 - 7295
12345